Search - tctmd.com

Displaying 961 - 980 of 1140

Sort: Relevancy | Date

Presentation TCT 2013

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Presenter: Paul Grayburn

October 30, 2013

Presentation TCT 2013

For Left Atrial Appendage Occlusion

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Safety and Early Efficacy of the Lariat Procedure: Results from the U.S. Transcatheter LAA Ligation Consortium

Presenter: Matthew J. Price

October 29, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Presentation TCT 2013

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Left Atrial Appendage Occlusion: What Success Looks Like

Presenter: Matthew Price

October 29, 2013

Presentation TCT 2013

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Left Atrial Appendage Occlusion Devices: Techniques and Different Devices

Presenter: Horst Sievert

October 29, 2013

Presentation TCT 2013

Introduction: Multifaceted Approaches to Atrial Fibrillation: From Drugs to Ablation to Left Atrial Appendage Closure

Presenter: Vivek Reddy

October 29, 2013

Presentation TCT 2013

Complication Following Left Atrial Appendage Occlusion

Presenter: Brian Whisenant

October 29, 2013

Presentation TCT 2013

Anatomical Effect on Left Atrial After Transcatheter Left Atrial Appendage Devices: Watchman and Amplatzer Cardiac Plug in a Canine Model

Presenter: Dongming Hou

October 29, 2013

Presentation TCT 2013

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 29, 2013

Presentation TCT 2013

Structural Intervention: LAA Closure, HOCM, Paravalvular Leak

Presenter: Anita Asgar

October 28, 2013

Presentation TCT 2013

Pro(2)

Presenter: Vivek Reddy

October 28, 2013

Presentation TCT 2013

Next Generation Devices for Left Atrial Appendage Occlusion

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Presenter: Juan Granada

October 28, 2013

Presentation TCT 2013

Didactic(4)

Presenter: Jessica Forman

October 28, 2013

Presentation TCT 2013

Con(2)

Presenter: Darryl Wells

October 28, 2013

Presentation TCT 2013

Case Presentation: LAA Exclusion in a Patient With Atrial Fibrillation

Presenter: Evgeny Merkulov

October 28, 2013

Advertisement

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

For Left Atrial Appendage Occlusion

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Safety and Early Efficacy of the Lariat Procedure: Results from the U.S. Transcatheter LAA Ligation Consortium

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Left Atrial Appendage Occlusion: What Success Looks Like

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Left Atrial Appendage Occlusion Devices: Techniques and Different Devices

Introduction: Multifaceted Approaches to Atrial Fibrillation: From Drugs to Ablation to Left Atrial Appendage Closure

Complication Following Left Atrial Appendage Occlusion

Anatomical Effect on Left Atrial After Transcatheter Left Atrial Appendage Devices: Watchman and Amplatzer Cardiac Plug in a Canine Model

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Structural Intervention: LAA Closure, HOCM, Paravalvular Leak

Pro(2)

Next Generation Devices for Left Atrial Appendage Occlusion

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Didactic(4)

Con(2)

Case Presentation: LAA Exclusion in a Patient With Atrial Fibrillation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content